Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Chongqing Lummy Pharmaceutical (300006)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.90 +0.02    +0.69%
30/04 - Closed. Currency in CNY ( Disclaimer )
  • Volume: 11,497,700
  • Bid/Ask: 2.90 / 2.90
  • Day's Range: 2.84 - 2.93
Type:  Equity
Market:  China
ISIN:  CNE100000H10 
Chongqing Lummy Pharmaceutical 2.90 +0.02 +0.69%

Chongqing Lummy Pharmaceutical Company Profile

 
Get an in-depth profile of Chongqing Lummy Pharmaceutical, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

905

Equity Type

ORD

Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. The company provides antibacterial, antifungal, antiviral agent, acid-base balance nutritional, liver auxiliary, Chinese patent, base large infusion drugs; American ginseng; and drugs for the treatment of tumors, as well as digestive, immune, blood, nervous, cardiovascular, and endocrinology systems. It also offers sodium bicarbonate injection. The company was founded in 1999 and is headquartered in Chongqing, China.

Contact Information

Address Building B, No. 2 Yangliu Road 15th and 16th Floors
Chongqing Institute of Science and Technology Huangshan Avenue, Yubei District Chongqing,401121
China
Phone 86 23 6730 0382
Fax 86 23 6730 0381

Top Executives

Name Age Since Title
Xue Feng Leng 52 2016 Deputy General Manager and Vice Chairman
Yuan Yuan 42 2017 Chairman of Supervisory Board
Geng Chen 51 2020 Independent Director
Xujiang Chen 51 2020 Independent Director
Jiansheng Liang 42 2021 Chairman
Song Lin 51 2022 Deputy GM & Director
Hai Run Wang 36 2023 Director
Changbi Li 52 2020 Independent Director
Weiyan Tang 39 2020 Director
Mingyue Tan 31 2021 Supervisor
Rihua Ou 48 2020 Director
Huichuan Xu 46 2014 Employee Supervisor
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

300006 Comments

Write your thoughts about Chongqing Lummy Pharmaceutical
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email